The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System
Abstract
CB1 cannabinoid receptors appear to mediate most, if not all of the psychoactive effects of delta-9-tetrahydrocannabinol and related compounds. This G protein-coupled receptor has a characteristic distribution in the nervous system: It is particularly enriched in cortex, hippocampus, amygdala, basal ganglia outflow tracts, and cerebellum--a distribution that corresponds to the most prominent behavioral effects of cannabis. In addition, this distribution helps to predict neurological and psychological maladies for which manipulation of the endocannabinoid system might be beneficial. CB1 receptors are primarily expressed on neurons, where most of the receptors are found on axons and synaptic terminals, emphasizing the important role of this receptor in modulating neurotransmission at specific synapses. While our knowledge of CB1 localization in the nervous system has advanced tremendously over the past 15 years, there is still more to learn. Particularly pressing is the need for (1) detailed anatomical studies of brain regions important in the therapeutic actions of drugs that modify the endocannabinoid system and (2) the determination of the localization of the enzymes that synthesize, degrade, and transport the endocannabinoids.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CB1R is the most densely expressed in the brain and is present at high levels in corticolimbic regions mediating anxiety, including the medial prefrontal cortex (mPFC) and hippocampus, as well as the BLA [11,14]”
From Amygdala FAAH and anandamide: mediating protection and recovery from stress (2013) · cites this paper as [14]
Citations
Cites
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Interneurons of the hippocampus
Freund, T. F., & Buzsáki, G. (1998) · Hippocampus · doi:10.1002/(sici)1098-1063(1996)6:4 · Cited by 3,478
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,616
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Self-citationBrain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citationCB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Marsicano, G., Goodenough, S., Monory, K., Hermann, H., Eder, M., Cannich, A., Azad, S. C., Cascio, M. G., Gutiérrez, S. O., van der Stelt, M., et al. (2003) · Science · doi:10.1126/science.1088208 · Cited by 1,208
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,085
Research works printed but not linked: 1
- Riegal AC, Williams JT, Lupica CR (2003) Cananbionid CB1 receptors inhibit GABA-Bmediated synaptic currents in midbrain dopaminergic neurons. Soc Neurosci Abstr 33:462466
Cited by
Sorted by citations
Items 401–500 of 751
Zhou, H., Shan, M., Qin, L., & Cheng, G. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106379 · Cited by 13
Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy
Micheli, L., Maggini, V., Ciampi, C., Gallo, E. R., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Mannelli, L. D. C., Leo, M. D., et al. (2022) · Phytotherapy Research · doi:10.1002/ptr.7709 · Cited by 13
Isır, A. B., Baransel, C., & Nacak, M. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0721-z · Cited by 13
Modulation of gastric acid secretion by cannabinoids in rats
Elgohary, R., Abdelsalam, R. M., Abdel‐Salam, O. M. E., Khattab, M. M., Salem, N. A., El‐Khyat, Z. A., Morsy, F. A., & Eldenshary, E. E.-D. S. (2018) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22256 · Cited by 13
Fuerte-Hortigón, A., Gonçalves-Sánchez, J., Zeballos, L., Masa, R., Gómez‐Nieto, R., & López, D. E. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.613798 · Cited by 16
Guzman, A. S., Avalos, M. P., Giovanni, L. N. D., Euliarte, P. V., Sanchez, M. A., Mongi‐Bragato, B., Rigoni, D., Bollati, F. A., Virgolini, M. B., & Cancela, L. M. (2021) · Scientific Reports · doi:10.1038/s41598-021-92389-4 · Cited by 13
Effects of prenatal exposure to THC on hippocampal neural development in offspring
Peng, H., Li, H., Wei, Y., Zhang, R., Chang, X., Meng, L., Wang, K., He, Q., & Duan, T. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.12.007 · Cited by 12
Li, Y., Zhi, W., Qi, B., Wang, L., & Hu, X. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1216524 · Cited by 16
Cannabinoids in the treatment of glioblastoma
Buchalska, B., Kamińska, K., Owe-Larsson, M., & Cudnoch‐Jędrzejewska, A. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00580-x · Cited by 12
Isaac, A. R., de Velasco, P. C., Fraga, K. Y. D., Tavares‐do‐Carmo, M. D. G., Campos, R. M. P., Iannotti, F. A., Verde, R., Martins, D. B. G., Santos, T. W. D. A., Ferreira, B. K., et al. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108782 · Cited by 12
Cannabinoid-induced changes in the immune system: The role of microRNAs
Bhatt, H. K., Song, D., Musgrave, G., & Rao, S. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107832 · Cited by 12
Kim, H. J. J., Zagzoog, A., Smolyakova, A.-M., Ezeaka, U. C., Benko, M. J., Holt, T., & Laprairie, R. B. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.790546 · Cited by 12
Postmortem redistribution of cannabinoids: Statistical analysis of a novel dataset and meta-analysis
Tascon, I., Côté, C., Garneau, B., Desharnais, B., Gosselin, V., & Mireault, P. (2023) · Forensic Science International · doi:10.1016/j.forsciint.2023.111873 · Cited by 12
Dumiaty, Y., Underwood, B. M., Phy‐Lim, J., & Chee, M. J. S. (2024) · Neuropeptides · doi:10.1016/j.npep.2024.102427 · Cited by 12
Bartkowiak-Wieczorek, J., Bienert, A., Czora-Poczwardowska, K., Kujawski, R., Szulc, M., Mikołajczak, P. Ł., Wizner, A.-M., Jamka, M., Hołysz, M., Wielgus, K., et al. (2024) · Biomolecules · doi:10.3390/biom14091065 · Cited by 12
Hassanzadeh, P., & Hassanzadeh, A. (2011) · Europe PMC (PubMed Central) · Cited by 12
Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI
Fatima, H., Howlett, A. C., & Whitlow, C. T. (2019) · British Journal of Radiology · doi:10.1259/bjr.20190165 · Cited by 13
Spigelman, I. (2009) · Frontiers in neuroscience · doi:10.1201/9781439812105-c5 · Cited by 12
Eroli, F., Loonen, I. C. M., van den Maagdenberg, A. M. J. M., Tolner, E. A., & Nistri, A. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.12.013 · Cited by 12
Zádor, F., Nagy-Grócz, G., Dvorácskó, S., Bohár, Z., Cseh, E. K., Zádori, D., Párdutz, Á., Szűcs, E., Tömböly, C., Borsodi, A. D., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104752 · Cited by 12
Ruiz‐Contreras, A. E., Delgado-Herrera, M., García-Vaca, P. A., Almeida-Rosas, G. A., Soria-Rodríguez, G., Soriano-Bautista, A., Cadena-Valencia, J., Bazán-Frías, J. R., Gomez‐Lopez, N., Espejel-Núñez, A., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.03.013 · Cited by 12
Jana, A., Nath, A., Sen, P., Kundu, S., Alghamdi, B. S. A., Abujamel, T. S., Saboor, M., Chan, W., Alexiou, A. T., Papadakis, M., et al. (2024) · NeuroMolecular Medicine · doi:10.1007/s12017-024-08781-6 · Cited by 11
Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder
Massey, S., Quigley, A. F., Rochfort, S. J., Christodoulou, J., & Bergen, N. J. V. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910768 · Cited by 11
Bunsick, D. A., Matsukubo, J., & Szewczuk, M. R. (2023) · Cancers · doi:10.3390/cancers15041030 · Cited by 11
McElroy, D. L., Roebuck, A. J., Scott, G. A., Greba, Q., Garai, S., Denovan‐Wright, E. M., Thakur, G. A., Laprairie, R. B., & Howland, J. G. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05755-x · Cited by 11
Giné, E., Echeverry‐Alzate, V., López‐Moreno, J. A., López‐Jiménez, A., Torres, D., Pérez‐Castillo, A., & Santos, Á. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.004 · Cited by 11
MacDowell, K. S., Sayd, A., García‐Bueno, B., Caso, J. R., Madrigal, J. L. M., & Leza, J. C. (2016) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2016.1151075 · Cited by 11
Constitutive Activity in Cannabinoid Receptors
Fong, T. M. (2014) · Advances in pharmacology · doi:10.1016/b978-0-12-417197-8.00004-3 · Cited by 11
Kho, D. T., Glass, M., & Graham, E. S. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.009 · Cited by 11
Fartootzadeh, R., Azizi, F., Alaei, H., & Reisi, P. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.01.027 · Cited by 11
Lindgren, L., Gouveia-Figueira, S. C., Nording, M. L., & Fowler, C. J. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1450-z · Cited by 11
Endocannabinoid System Biomarkers in Alzheimer's Disease
Ferreira, P. C. L., Bellaver, B., Povala, G., Brum, W. S., Tissot, C., Badji, A., Sloan, M. E., Benedet, A. L., Rosa‐Neto, P., Ashton, N. J., et al. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0151 · Cited by 11
Cannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels
Erustes, A. G., Abílio, V. C., Bincoletto, C., Piacentini, M., Pereira, G. J. S., & Smaili, S. S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149414 · Cited by 10
Deurwaerdère, P. D., Casarrubea, M., Cassar, D., Radic, M., Puginier, E., Chagraoui, A., Crescimanno, G., Crunelli, V., & Giovanni, G. D. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.886033 · Cited by 10
Kim, H. J. J., Zagzoog, A., Black, T., Baccetto, S. L., & Laprairie, R. B. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.06.010 · Cited by 10
The endogenous cannabinoid system modulates male sexual behavior expression
Rodríguez–Manzo, G., & Canseco-Alba, A. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1198077 · Cited by 11
Premoli, M., Fyke, W., Bellocchio, L., Lemaire, V., Woolley-Roberts, M., Bontempi, B., & Pietropaolo, S. (2023) · Cells · doi:10.3390/cells12151927 · Cited by 10
Daigle, T. L., Wetsel, W. C., & Caron, M. G. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07874.x · Cited by 10
Kondev, V., Bluett, R. J., Najeed, M., Rosas-Vidal, L. E., Grueter, B. A., & Patel, S. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100510 · Cited by 10
Regulation of Neuronal Protein Trafficking and Translocation by SUMOylation
Berndt, A., Wilkinson, K. A., & Henley, J. M. (2012) · Biomolecules · doi:10.3390/biom2020256 · Cited by 10
Sleep and neurochemical modulation by cannabidiolic acid methyl ester in rats
Murillo‐Rodríguez, E., Arankowsky‐Sandoval, G., Pertwee, R. G., Parker, L. A., & Mechoulam, R. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.12.006 · Cited by 10
Hansen, H. S., Petersen, G. L., Artmann, A., & Madsen, A. N. (2006) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200600157 · Cited by 10
Gunasekera, B., Davies, C., Blest-Hopley, G., Veronese, M., Ramsey, N. F., Bossong, M. G., Radua, J., Bhattacharyya, S., Pretzsch, C., McAlonan, G., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104801 · Cited by 10
Kalak, P., Kupczyk, P., Szumny, A. J., Gębarowski, T., Jasiak, M., Niedźwiedź, А., Niżański, W., & Dzięcioł, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157095 · Cited by 9
The endocannabinoid system in the visual process
Pasquaré, S. J., Chamorro-Aguirre, E., & Gaveglio, V. L. (2022) · Journal of Photochemistry and Photobiology · doi:10.1016/j.jpap.2022.100159 · Cited by 9
Adolescent exposure to low-dose Δ9-tetrahydrocannabinol depletes the ovarian reserve in female mice
Lim, J., Lee, H.-L., Nguyen, J. K., Shin, J. H., Getze, S., Quach, C., Squire, E., Jung, K., Mahler, S. V., Mackie, K., et al. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfad027 · Cited by 9
Self-citationBai, X., Batallé, G., Martínez-Martel, I., & Pol, O. (2023) · Antioxidants · doi:10.3390/antiox12061179 · Cited by 9
Gut bacteria, endocannabinoid system, and marijuana addiction: Novel therapeutic implications
Pinapati, K. K., Vidya, S., Khan, M. F., Mandal, D., & Banerjee, S. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100144 · Cited by 9
Xue, T., Ma, R.-H., Xu, C., Sun, B., Yan, D.-F., Liu, X., Gao, D., Li, Z., Gao, Y., & Wang, C. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1366855 · Cited by 9
Durydivka, O., Palivec, P., Gazdarica, M., Mackie, K., Blahoš, J., & Kuchař, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-58845-7 · Cited by 9
Self-citationEndocannabinoid Signaling in Neural Circuits of the Olfactory and Limbic System
Heinbockel, T., Wang, Z., Brown, E. A., & Austin, P. T. (2016) · InTech eBooks · doi:10.5772/63214 · Cited by 9
Perspectives on the Role of Endocannabinoids in Autism Spectrum Disorders
Yeh, M. L., & Levine, E. S. (2017) · OBM Neurobiology · doi:10.21926/obm.neurobiol.1702005 · Cited by 9
Emerich, B. L., Ferreira, R. C. M., Machado‐de‐Ávila, R. A., Resende, J. M., Duarte, I. D. G., & de Lima, M. E. (2020) · Toxicon X · doi:10.1016/j.toxcx.2020.100045 · Cited by 9
Trinidad, L. L., Martínez, R., Kapravelou, G., Galisteo, M., Aranda, P., Porres, J. M., & López‐Jurado, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83709-9 · Cited by 9
Food and Toxicologic Pathology
Pulido, O. M., Rousseaux, C. G., & Cole, P. I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-16153-7.00002-2 · Cited by 8
A systematic study of molecular targets of cannabidiol in Alzheimer's disease
Patil, N., Patil, K., Jain, M., Mohammed, A., Yadav, A., Dhanda, P. S., Kole, C., Dave, K., Kaushik, P., Razab, M. K. A. A., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241284464 · Cited by 8
Jones, A. A., Purohit, R., Bhatt, T. S., & Motl, R. W. (2025) · CNS Drugs · doi:10.1007/s40263-025-01159-7 · Cited by 8
Krowicki, Z. K. (2012) · PubMed · Cited by 8
Pascual, A. C., Gaveglio, V. L., Giusto, N. M., & Pasquaré, S. J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.042 · Cited by 8
Cai, S., Guo, Z., Wang, X., Huang, K., Yuan, K., & Huang, L. (2022) · Cerebral Cortex · doi:10.1093/cercor/bhac103 · Cited by 8
Prospects for cannabinoid therapies in viral encephalitis
Solbrig, M. V., Fan, Y., & Hazelton, P. R. (2013) · Brain Research · doi:10.1016/j.brainres.2013.08.032 · Cited by 8
Simkins, T., Fried, D. E., Parikh, K. A., Galligan, J. J., Goudreau, J. L., Lookingland, K. J., & Kaplan, B. L. F. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9689-2 · Cited by 8
Zou, S., & Kumar, U. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104518 · Cited by 8
Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum
Toschi, A., Galiazzo, G., Piva, A., Tagliavia, C., Mazzuoli‐Weber, G., Chiocchetti, R., & Grilli, E. (2021) · Animals · doi:10.3390/ani11020263 · Cited by 8
Lillo, A., Lillo, J., Raïch, I., Miralpeix, C., Dosrius, F., Franco, R., & Navarro, G. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.786597 · Cited by 8
Chapter 4.5 The endocannabinoid system and anxiety responses
Bortolato, M., & Piomelli, D. (2008) · Handbook of Behavioral Neuroscience · doi:10.1016/s1569-7339(07)00014-8 · Cited by 7
Ceccarini, J., Koole, M. J. B., & Laere, K. V. (2022) · Addiction Biology · doi:10.1111/adb.13167 · Cited by 7
Rosado‐Franco, J. J., Ellison, A. L., White, C. J., Price, A., Moore, C., Williams, R. E., Fridman, L., Weerts, E. M., & Williams, D. W. (2024) · Physiological Reports · doi:10.14814/phy2.15947 · Cited by 7
Bortolato, M., Braccagni, G., Pederson, C. A., Floris, G., & Fite, P. J. (2024) · Aggression and Violent Behavior · doi:10.1016/j.avb.2024.101948 · Cited by 7
Aquaporin 4 and the endocannabinoid system: a potential therapeutic target in brain injury
Martínez-Torres, A. M., & Morán, J. (2024) · Experimental Brain Research · doi:10.1007/s00221-024-06896-7 · Cited by 7
Growth hormone secretagogue receptor and cannabinoid receptor type 1 intersection in the mouse brain
Saenz, C., Fernández, G., Llovera, R. E., Tolosa, M. J., Cantel, S., Fehrentz, J., Mackie, K., Leggio, L., Zigman, J. M., Francesco, P. N. D., et al. (2024) · Brain Structure and Function · doi:10.1007/s00429-024-02876-3 · Cited by 7
Self-citationDo the effects of cannabis on the hippocampus and striatum increase risk for psychosis?
Daniju, Y., Bossong, M. G., Brandt, K. R., & Allen, P. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.02.010 · Cited by 7
The Role of Cannabinoids in CNS Development: Focus on Proliferation and Cell Death
Bockmann, E. C., Brito, R., Madeira, L. F., Sampaio, L. D. S., Reis, R. A. D. M., França, G. R., & Calaza, K. D. C. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01263-y · Cited by 8
Saumell-Esnaola, M., Elejaga-Jimeno, A., Echeazarra, L., Roman, L. B., Barrondo, S., de Jesús, M. L., González‐Burguera, I., Gómez‐Caballero, A., Goicolea, M. A., Sallés, J., et al. (2022) · Microbial Cell Factories · doi:10.1186/s12934-022-01914-1 · Cited by 7
Caltana, L. R., Heimrich, B., & Brusco, A. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0499-4 · Cited by 7
Endocannabinoid mechanism in amphetamine-type stimulant use disorders: A short review
Su, H., & Zhao, M. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.08.042 · Cited by 7
Cannabinoids in Autoimmune and Rheumatic Diseases
Navarini, L., Margiotta, D. P. E., Afflitto, G. G., & Afeltra, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814307-0.00038-4 · Cited by 7
Wadea, N. E., Issac, M. M., Osman, N. A., & Abadi, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0172 · Cited by 7
Yang, C., Nolte, I. M., Ma, Y., An, X., Bosker, F. J., & Li, J. (2021) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1752 · Cited by 7
Wilkinson, M., & Brown, R. E. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139045803.006 · Cited by 7
Khara, L. S., & Ali, D. W. (2023) · Physiological Reports · doi:10.14814/phy2.15565 · Cited by 7
Krohmer, A., Brehm, M., Auwärter, V., & Szabó, B. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.032 · Cited by 9
Endocannabinoid Role in Synaptic Plasticity and Learning
Lutz, B., & Marsicano, G. (2009) · Elsevier eBooks · doi:10.1016/b978-008045046-9.00816-0 · Cited by 7
Bockstaele, E. J. V. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.01.002 · Cited by 7
Sobieraj, J., Strzelecka, K., Sobczak, M., & Olędzka, E. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s458907 · Cited by 7
CB1 receptor signaling: Linking neuroplasticity, neuronal types, and mental health outcomes
Gao, Q., & Asim, M. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.105938 · Cited by 6
The CB1 receptor: linking impulsivity and substance use disorder
Belmont, O. A., Becerril-Meléndez, L. A., & Méndez‐Díaz, M. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1621242 · Cited by 6
Overlapping pathways of migraine and the endocannabinoid system: Potential therapeutic targets
Pietra, A. D., & Russo, A. F. (2026) · Neurotherapeutics · doi:10.1016/j.neurot.2026.e00833 · Cited by 6
Overview of the Endocannabinoid System and Endocannabinoidome
Davis, M. P. (2022) · Springer eBooks · doi:10.1007/978-3-030-89918-9_1 · Cited by 6
Potential perioperative cardiovascular outcomes in cannabis/cannabinoid users. A call for caution
Echeverria-Villalobos, M., Guevara, Y., Mitchell, J., Ryskamp, D., Conner, J., Bush, M., Periel, L., Uribe, A. A., & Weaver, T. E. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1343549 · Cited by 6
Rezende, B., Marques, K. L., de Carvalho, F. E. A., Gonçalves, V. M. D. S., de Oliveira, B. C. C. A., Nascimento, G. G., dos Santos, Y. B., Antunes, F., Barradas, P. C., Fontes-Dantas, F. L., et al. (2024) · Scientia Pharmaceutica · doi:10.3390/scipharm92030053 · Cited by 6
Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons
Rivas‐Santisteban, R., Muñoz, A., Lillo, J., Raïch, I., Rodriguez-Perez, A. I., Navarro, G., Labandeira-García, J. L., & Franco, R. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00827-7 · Cited by 6
Tyler, J. R., Park, Y., Lu, H., Roeder, N. M., Richardson, B., Gold, M. S., Blum, K., Pinhasov, A., Baron, D. A., & Thanos, P. K. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.038 · Cited by 6
Antinori, S., & Fattore, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_2 · Cited by 6
Fartootzadeh, R., Alaei, H., & Reisi, P. (2021) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.310524 · Cited by 6
Cannabis: Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin
Canseco-Alba, A., & Rodrı́guez–Manzo, G. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000112 · Cited by 6
The Corticostriatal Pathway in Parkinson’s Disease
Bamford, N. S., & Cepeda, C. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-252-0_6 · Cited by 6
Association of CNR1 gene and cannabinoid 1 receptor protein in the human brain
Pak, K., Kantonen, T., Pekkarinen, L., Nuutila, P., & Nummenmaa, L. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25149 · Cited by 7
Bobrov, М. Y., Безуглов, В. В., Хаспеков, Л. Г., Illarioshkin, S. N., Novosadova, E. V., & Grivennikov, I. A. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3782-2 · Cited by 6
Hassan, A. H. E., Park, K. T., Kim, H. J., Lee, H. J., Kwon, Y. H., Hwang, J. Y., Jang, C., Chung, J. H., Park, K. D., Lee, S. J., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103834 · Cited by 6
Metadata
- Authors
- Mackie, K.
- Affiliations
- University of Washington (US)
- Corresponding author
- Mackie, K.
- ORCID
- Mackie, K.
- Venue
- Handbook of Experimental Pharmacology
- Publisher
- Springer-Verlag
- Published
- 2005-12-23
- Issue
- 168
- Pages
- 299-325
- OpenAlex
- W2149183149
- Cited by
- 744
- References
- 103
- Citations by year
- 2026: 28 · 2025: 38 · 2024: 47 · 2023: 56 · 2022: 59 · 2021: 69 · 2020: 48 · 2019: 52 · 2018: 40 · 2017: 37 · 2016: 33 · 2015: 31 · 2014: 26 · 2013: 27 · 2012: 32
- FWCI
- 26.30
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Springer eBooks (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (DA00286, DA11322, R01DA011322, K02DA000286)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- CB1 receptor, cannabinoid receptors, endocannabinoid system, delta-9-tetrahydrocannabinol, G protein-coupled receptors, receptor distribution, central nervous system, peripheral nervous system, hippocampus, amygdala, cerebellum, basal ganglia, neurotransmission
- MeSH terms
- Animals, Autoradiography, Central Nervous System, Humans, Immunohistochemistry, In Situ Hybridization, Peripheral Nervous System, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review